Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDV and 9vHPV Co-administration in Adolescents
NCT04313244Phase 3Completed
- Sponsor
- Takeda
- Start
- May 2021
- Primary completion
- Feb 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of dengue tetravalent vaccine (live, attenuated) in dengue fever, sponsored by Takeda. Started May 2021; status: completed.
02
Drugs
dengue tetravalent vaccine (live, attenuated)
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT04313244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04313244.